Merger with AlloVir (Tables)

6 Months Ended

Jun. 30, 2025

Business Combination [Abstract]

Schedule of Number of Shares Common Stock Issued and Outstanding

The number of shares of the Company's common stock issued and outstanding immediately following the closing of the Merger was as follows:

AlloVir’s common stock outstanding	5,043,652
AlloVir’s restricted stock units accelerated and settled in common stock	24,022
Common stock issued to Legacy Kalaris' securityholders at the Effective Time	13,634,744
	18,702,418